Coding Bio

Drug Discovery · Oxford, United Kingdom · Founded 2020 · Privately Held (backing)

Developer of a cell discovery platform designed to accelerate the development of new targets for chimeric antigen receptors. Coding Bio is based in Oxford, United Kingdom and was founded in 2020. It was valued at $6.6 million at its seed round in Sep 2023, the last priced event on record. It has raised $3.6 million across 1 recorded round; the latest was a $3.6 million seed round in Sep 2023.

PMV mark · valuation
$6.6M
Oct 2026
Priced at
its seed round
Sep 2023
Total raised
$3.6M
Last round
Seed Round
Sep 2023
What is Coding Bio worth?
$6.6MPrivateMarketView mark · Oct 2026

Valued at $6.6M at its seed round, Sep 2023. Nothing has traded since.

Free account
More of Coding Bio with a free account
  • ·The complete investor list: 15 names
  • ·Watch Coding Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Coding Bio funding history

1 rounds
DateRoundRaisedPost-money
Sep 2023Seed Round$3.6M▮
Unlock post-money valuations

Membership and data by Private Market View

Coding Bio valuation

Coding Bio was valued at $6.6 million at its seed round in Sep 2023. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Coding Bio raised?

Coding Bio has raised $3.6 million across 1 recorded round since 2023. The largest was a $3.6 million seed round in Sep 2023.

Comparable companies

Comparable drug discovery names by valuation on PrivateMarketView: Ancilia Bio ($28 million), PAhR Therapeutics ($25 million) and Valink Therapeutics ($12.6 million).

How Coding Bio's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Coding Bio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Coding Bio

What is Coding Bio worth?
Coding Bio is valued at $6.6M as of Oct 2026. Valued at $6.6M at its seed round, Sep 2023. Nothing has traded since.
How much has Coding Bio raised?
Coding Bio has raised $3.6M in total funding across 1 recorded rounds.
When did Coding Bio last raise?
Coding Bio last raised in Sep 2023 (Seed Round), raising $3.6M.